1. Dagdelen S, and Batur MK. “Interventional therapy in resistanthypertension; new renal denervation applications in Turkiye/Direnclihipertansiyonda girisimsel tedavi; Turkiye’deki yeni renal denervasyonuygulamalari.” The Anatolian Journal of Cardiology (AnadoluKardiyoloji Dergisi).2012:12.(2)187-188.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J.Global burden of hypertension: analysis of worldwide data. Lancet. 15-21;365(9455):217-223. doi: 10.1016/S0140-6736(05)17741-1
3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospectivestudies collaboration. age-specific relevance of usual blood pressure tovascular mortality: a meta-analysis of individual data for one millionadults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-1913. doi: 10.1016/s0140-6736(02)11911-8
4. Pisano A, Iannone LF, Leo A, Russo E, Coppolino G, Bolignano D.Renal denervation for resistant hypertension. Cochrane Database SystRev. 2021 Nov 22;11(11):CD011499. doi: 10.1002/14651858.CD011499
5. Gupta A, Prince M, Bob-Manuel T, Jenkins JS. Renal denervation:Alternative treatment options for hypertension? Prog Cardiovasc Dis.2020;63(1):51-57. doi: 10.1016/j.pcad.2019.12.007
6. Mahfoud, Felix, et al. “Ambulatory blood pressure changes after renalsympathetic denervation in patients with resistant hypertension.”Circulation 128.2 (2013): 132-140.
7. Kandzari DE, Böhm M, Mahfoud F, et al. “Long-term effects of renalartery denervation on blood pressure and safety in patients withresistant hypertension (SYMPLICITY HTN-3): 3-year follow-up resultsof a randomised controlled trial. The Lancet. 2018:2340-2348
8. Bhatt, Deepak L., et al. “A controlled trial of renal denervation forresistant hypertension.” New England Journal of Medicine 370.15(2014): 1393-1401.